Ligand validation:8ET4

AUJ: 2-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-2-[(1~{S})-1-(dioxidanyl)-1-oxidanyl-ethyl]-4-methyl-1,3-thiazol-5-yl]ethyl phosphono hydrogen phosphate

AUJ is a Ligand Of Interest in 8ET4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8ET4_AUJ_A_706	61%	12%	0.191	0.982	2.14	1.94	6	11	0	0	100%	0.9458
9C4R_AUJ_A_703	96%	13%	0.071	0.982	2.2	1.75	8	11	0	0	100%	0.8984
9C4Q_AUJ_A_704	92%	13%	0.09	0.981	2.22	1.75	8	10	0	0	100%	0.8568
9C4P_AUJ_A_706	92%	14%	0.088	0.977	2.18	1.69	7	10	0	0	100%	0.831
8ET5_AUJ_A_705	42%	12%	0.253	0.974	2.14	1.91	6	11	0	0	100%	0.8558
7TZZ_AUJ_A_704	32%	7%	0.275	0.951	2.67	2.27	7	14	0	0	100%	0.81
5WKC_AUJ_A_705	71%	10%	0.149	0.971	2.71	1.64	12	7	1	0	100%	0.9458

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.